Current Gene Therapy

2.2(top 20%)

impact factor

947(top 20%)

papers

28.5K(top 10%)

citations

80(top 10%)

h-index

2.2(top 20%)

impact factor

1.1K

all documents

30.1K

doc citations

118(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	New Recombinant Serotypes of AAV Vectors	Current Gene Therapy	2005	461
2	Altering the Tropism of Lentiviral Vectors through Pseudotyping	Current Gene Therapy	2005	457
3	Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy	Current Gene Therapy	2014	411
4	From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy	Current Gene Therapy	2003	337
5	Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy	Current Gene Therapy	2011	326
6	Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application	Current Gene Therapy	2003	260
7	Immune Responses to AAV in Clinical Trials	Current Gene Therapy	2011	253
8	Tet-On Systems For Doxycycline-inducible Gene Expression	Current Gene Therapy	2016	253
9	Meganucleases and DNA Double-Strand Break-Induced Recombination: Perspectives for Gene Therapy	Current Gene Therapy	2007	249
10	Intracellular Barriers to Non-Viral Gene Transfer	Current Gene Therapy	2002	201
11	Immune Responses to Adeno-Associated Virus Vectors	Current Gene Therapy	2005	201
12	Polymer-Based Gene Delivery: A Current Review on the Uptake and Intracellular Trafficking of Polyplexes	Current Gene Therapy	2008	200
13	miR-122 is a Unique Molecule with Great Potential in Diagnosis, Prognosis of Liver Disease, and Therapy Both as miRNA Mimic and Antimir	Current Gene Therapy	2015	183
14	Immune Responses to AAV in Clinical Trials	Current Gene Therapy	2007	176
15	Current Advances and Future Challenges in Adenoviral Vector Biology and Targeting	Current Gene Therapy	2007	174
16	Electroporation-Enhanced Nonviral Gene Transfer for the Prevention or Treatment of Immunological, Endocrine and Neoplastic Diseases	Current Gene Therapy	2006	173
17	AAV Hybrid Serotypes: Improved Vectors for Gene Delivery	Current Gene Therapy	2005	169
18	Gene Electrotransfer: A Mechanistic Perspective	Current Gene Therapy	2016	168
19	Exosomes and the Emerging Field of Exosome-Based Gene Therapy	Current Gene Therapy	2012	166
20	Electroporation Gene Therapy Preclinical and Clinical Trials for Melanoma	Current Gene Therapy	2010	158
21	Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy	Current Gene Therapy	2014	156
22	BMP-9 Induced Osteogenic Differentiation of Mesenchymal Stem Cells: Molecular Mechanism and Therapeutic Potential	Current Gene Therapy	2011	150
23	Adenoviral Vector Immunity: Its Implications and Circumvention Strategies	Current Gene Therapy	2011	148
24	Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy	Current Gene Therapy	2001	144
25	Adeno-Associated Virus (AAV) Vectors in the CNS	Current Gene Therapy	2005	144
26	Immune Responses to Adenovirus and Adeno-Associated Vectors Used for Gene Therapy of Brain Diseases: The Role of Immunological Synapses in Understanding the Cell Biology of Neuroimmune Interactions	Current Gene Therapy	2007	144
27	Current Strategies and Future Directions for Eluding Adenoviral Vector Immunity	Current Gene Therapy	2006	143
28	Promoters and Control Elements: Designing Expression Cassettes for Gene Therapy	Current Gene Therapy	2004	142
29	Gemini Surfactants: A New Family of Building Blocks for Non-Viral Gene Delivery Systems	Current Gene Therapy	2008	139
30	Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders	Current Gene Therapy	2008	139
31	Why Do We Need New Gene Therapy Viral Vectors? Characteristics, Limitations and Future Perspectives of Viral Vector Transduction	Current Gene Therapy	2004	139
32	Biomaterials for Gene Delivery Atelocollagen-mediated Controlled Release of Molecular Medicines	Current Gene Therapy	2001	137
33	Baculoviral Vectors for Gene Delivery: A Review	Current Gene Therapy	2008	137
34	Progress in Cationic Lipid-Mediated Gene Transfection: A Series of Bio- Inspired Lipids as an Example	Current Gene Therapy	2008	137
35	Targeting Transcription Factors for Cancer Gene Therapy	Current Gene Therapy	2006	134
36	Non-Viral Gene Delivery to Mesenchymal Stem Cells: Methods, Strategies and Application in Bone Tissue Engineering and Regeneration	Current Gene Therapy	2011	132
37	Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors	Current Gene Therapy	2003	132
38	Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting	Current Gene Therapy	2011	131
39	Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.	Current Gene Therapy	2002	129
40	Current Advances in Retroviral Gene Therapy	Current Gene Therapy	2011	129
41	The φC31 Integrase System for Gene Therapy	Current Gene Therapy	2006	127
42	The Poxvirus Vectors MVA and NYVAC as Gene Delivery Systems for Vaccination Against Infectious Diseases and Cancer	Current Gene Therapy	2008	127
43	Separating Fact from Fiction: Assessing the Potential of Modified Adenovirus Vectors for Use in Human Gene Therapy	Current Gene Therapy	2002	123
44	Retroviral Gene Therapy: Safety Issues and Possible Solutions	Current Gene Therapy	2005	117
45	The Sodium Iodide Symporter (NIS) as an Imaging Reporter for Gene, Viral, and Cell-based Therapies	Current Gene Therapy	2012	114
46	Production, Purification and Characterization of Adeno-Associated Vectors	Current Gene Therapy	2010	113
47	TGF-b: A Fibrotic Factor in Wound Scarring and a Potential Target for Anti- Scarring Gene Therapy	Current Gene Therapy	2004	113
48	Therapeutic Angiogenesis using Hepatocyte Growth Factor (HGF)	Current Gene Therapy	2004	110
49	State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations	Current Gene Therapy	2009	109
50	Transposons for Gene Therapy!	Current Gene Therapy	2006	108

Scientometrics

Overviews

Citing Bodies

Current Gene Therapy

Top Articles